Valeo Financial Advisors’s Editas Medicine EDIT Stock Holding History

Valeo Financial Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.5K	Hold	10,042	–	–	﹤0.01%	819
2026 Q1	$24.8K	Buy	+10,042	New	+$21.3K	﹤0.01%	737
2021 Q4	–	Sell	-5,959	Closed	-$245K	–	604
2021 Q3	$245K	Sell	5,959 -111	-2%	-$6.08K	0.01%	445
2021 Q2	$344K	Buy	6,070 +128	+2%	+$4.73K	0.02%	337
2021 Q1	$250K	Buy	5,942 +2,042	+52%	+$116K	0.01%	390
2020 Q4	$273K	Hold	3,900	–	–	0.01%	359
2020 Q3	$109K	Sell	3,900 -5	-0.1%	-$163	0.01%	462
2020 Q2	$116K	Buy	3,905 +3,417	+700%	+$89.3K	0.01%	459
2020 Q1	$11K	Sell	488 -480	-50%	-$12.1K	﹤0.01%	1055
2019 Q4	$29K	Buy	968 +480	+98%	+$12K	﹤0.01%	823
2019 Q3	$11K	Sell	488 -40	-8%	-$991	﹤0.01%	1000
2019 Q2	$13K	Hold	528	–	–	﹤0.01%	955
2019 Q1	$13K	Buy	528 +413	+359%	+$9.35K	﹤0.01%	883
2018 Q4	$3K	Hold	115	–	–	﹤0.01%	1198
2018 Q3	$3K	Buy	115 +75	+188%	+$2.42K	﹤0.01%	1339
2018 Q2	$1K	Sell	40 -20	-33%	-$708	﹤0.01%	1447
2018 Q1	$2K	Sell	60 -20	-25%	-$713	﹤0.01%	1321
2017 Q4	$2K	Hold	80	–	–	﹤0.01%	1177
2017 Q3	$2K	Buy	+80	New	+$1.52K	﹤0.01%	1011

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Valeo Financial Advisors's EDIT Position: Q2 2026 in Review

Valeo Financial Advisors held its Editas Medicine (EDIT) position steady in Q2 2026 at 10,042 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Valeo Financial Advisors first reported a position in EDIT in Q3 2017 and has held it in 19 quarters since. The position peaked at $344K in Q2 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Valeo Financial Advisors held 10,042 shares of Editas Medicine worth $32.5K as of Q2 2026.
Valeo Financial Advisors left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #819 holding.
Valeo Financial Advisors first reported a position in Editas Medicine in Q3 2017 and has held it in 19 quarters since.
Valeo Financial Advisors's Editas Medicine position peaked at $344K in Q2 2021.
214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.